Are you a student enrolled in the BS Molecular Medicine program at Ziauddin University? Do you struggle with taking effective study notes that help you excel in your courses? Well, you’re in luck! In this article, we will provide you with expert tips and guidelines on how to create comprehensive study notes that will boost your understanding and retention of key concepts in molecular medicine.

Study Notes BS Molecular Medicine Ziauddin University.

BS MOLECULAR MEDICINE: COMPLETE STUDY NOTES

---

COURSE OVERVIEW

The Bachelor of Science (BS) in Molecular Medicine is a cutting-edge 4-year undergraduate program designed to meet the growing demand for specialized education in this field of medical research . The program presents a distinctive opportunity for aspiring scientists to explore the future of healthcare. Recognized as “tomorrow’s medicine,” Molecular Medicine is an advancing field that focuses on comprehending diseases at a molecular and genetic level, revolutionizing diagnostic and therapeutic approaches . The curriculum covers essential topics in basic and preclinical sciences, bridging the gap between fundamental science and clinical application .

---

PART ONE: FOUNDATIONAL SCIENCES

1.1 Molecular Biology

Molecular biology forms the core of the program, providing the essential framework for understanding life at a molecular level.

Core Concepts:

• DNA, RNA, and Protein: Understanding the structure and function of these key biological macromolecules is fundamental. This includes DNA replication, transcription (RNA synthesis), and translation (protein synthesis) .

• Gene Regulation: Explore how cells control the expression of their genes, from the basics of operons to complex eukaryotic regulatory mechanisms, including epigenetic modifications like DNA methylation .

• Genomics and Systems Biology: The program integrates genomics and systems biology to understand how the entire genome functions and interacts within biological systems .

Current Research Context: The University of Western Australia’s Molecular Medicine unit emphasizes that students will “demonstrate an understanding of DNA and chromosome structure and function… and demonstrate an understanding of basic gene regulation and structure” .

1.2 Genetics

Genetics provides the framework for understanding heredity, variation, and the molecular basis of both monogenic and complex diseases.

Core Concepts:

• Mendelian and Chromosomal Genetics: Study the fundamental principles of inheritance, including patterns of Mendelian inheritance and the chromosomal theory of inheritance .

• Medical Genetics: Explore how genetic variations contribute to human disease, including monogenic diseases, genetic heterogeneity of tumors, and the role of genomics in clinical practice .

• Gene Therapy: Investigate the theoretical concepts and current clinical applications of gene therapy, including the use of viral vectors and other delivery systems .

Current Research Context: Trinity College Dublin’s Molecular Medicine program includes a module specifically dedicated to Medical Genetics, underscoring its importance in the field .

1.3 Biochemistry

Biochemistry provides the chemical foundation for understanding metabolic processes and molecular interactions.

Core Concepts:

• Biological Macromolecules: Study the structure and function of carbohydrates, lipids, proteins, and nucleic acids .

• Metabolism: Understand the fundamental pathways of catabolism and anabolism and their role in health and disease .

• Protein Folding and Modification: Explore the critical processes of protein folding, post-translational modifications, and the consequences of protein aggregation in disease .

Program Integration: Ziauddin University offers Biochemistry I and Biochemistry II as core courses in the first year of the program, ensuring a strong foundation in these principles .

1.4 Human Anatomy and Physiology

Understanding the structure and function of the human body is essential for connecting molecular mechanisms to clinical applications.

Core Concepts:

• Cellular Physiology: Study the functions of the cell membrane, transport of substances across membranes, cell volume regulation, and the mechanics of the cell .

• Organ System Integration: Understand how the molecular and cellular processes studied in the program contribute to the function of different organ systems.

Program Integration: The curriculum at Ziauddin University integrates Anatomy and Physiology courses early in the program, recognizing their importance as a foundation for more advanced molecular topics .

---

PART TWO: ADVANCED MEDICAL TOPICS

2.1 Immunology

Immunology is a cornerstone of Molecular Medicine, exploring the complex defense mechanisms of the body.

Core Concepts:

• Immune System Fundamentals: Study innate and adaptive immunity, including the structure of the immune system, signaling pathways, and the regulation of immune responses .

• Immunopathology: Understand how dysregulation of the immune system leads to disease, including autoimmune diseases, immunodeficiencies, and hypersensitivity reactions .

• Immunotherapy: Explore the use of monoclonal antibodies, adoptive cell therapy, and other immunotherapies in treating diseases, particularly cancer .

Current Research Context: The program covers immunometabolism and the interactions between the immune system and other systems, such as the central nervous system, reflecting current research trends .

2.2 Molecular Oncology (Cancer Research)

Molecular oncology examines the genetic and cellular changes that drive cancer.

Core Concepts:

• Cancer Biology: Understand the hallmarks of cancer, including uncontrolled cell proliferation, evasion of apoptosis, and metastasis .

• Oncogenes and Tumor Suppressors: Study the genes that drive cancer development and the pathways they affect.

• Targeted Therapy: Explore the development and application of molecularly targeted therapies, including the mechanisms of resistance to these drugs .

Current Research Context: The Imperial College London program includes a dedicated module on the biology of breast, prostate, and lung cancer .

2.3 Hematology

Hematology focuses on disorders of the blood and blood-forming tissues.

Core Concepts:

• Hematopoiesis: Understand the process of blood cell formation from stem cells.

• Regulation of Coagulation: Study the molecular mechanisms of blood clotting and the disorders that arise from dysregulation .

• Hematological Malignancies: Explore the molecular underpinnings of leukemias, lymphomas, and other blood cancers.

Current Research Context: The field increasingly uses molecular diagnostics for classification and treatment of hematological disorders.

2.4 Neurobiology

Neurobiology explores the molecular basis of nervous system function and disease.

Core Concepts:

• Basic Neurobiology: Understand the structure and function of neurons, neurotransmission, and neural circuits .

• Molecular Mechanisms of Neurological Disease: Explore how molecular defects contribute to conditions such as neurodegenerative disorders, multiple sclerosis, and other neuroimmunological diseases .

• Neuroimmunology: Investigate the complex interactions between the nervous and immune systems in health and disease .

Current Research Context: The field is rapidly advancing, with increasing recognition of the role of the immune system in neurological disorders.

---

PART THREE: STRUCTURE OF THE BS MOLECULAR MEDICINE PROGRAM

3.1 Curriculum Overview

A typical BS Molecular Medicine program integrates foundational sciences with advanced medical topics. The curriculum is designed to bridge the gap between fundamental science and clinical application .

Program Insight: Ziauddin University’s program is designed to “inspire and equip curious minds with both theoretical knowledge and practical research experience” .

3.2 Teaching and Learning Methods

The program combines a variety of teaching and learning methods to develop both theoretical knowledge and practical research skills .

• Didactic and Interactive Lectures: Provide the core theoretical framework and facilitate discussion.

• Research Projects: Offer hands-on experience in planning and conducting research, including the use of state-of-the-art techniques .

• Laboratory-Based Sessions: Develop practical skills in experimental design and data analysis .

• Group Work and Tutorials: Foster collaboration, critical thinking, and problem-solving skills .

• Literature Review and Self-Directed Learning: Develop the ability to synthesize and critically evaluate primary scientific literature .

3.3 Assessment Methods

Assessment is designed to evaluate both knowledge and skills.

• Written Examinations: Assess understanding of core concepts and the ability to integrate knowledge.

• Practical Assessments: Evaluate competency in laboratory techniques and experimental design .

• Research Thesis/Report: Demonstrate the ability to design, conduct, and communicate a research project .

• Data Interpretation Exercises: Develop analytical skills in interpreting complex data .

• Research Paper Critique: Develop the ability to critically appraise primary literature .

---

REVIEW QUESTIONS

Sample Theoretical Questions

1. Describe the central dogma of molecular biology and explain its significance in the context of gene therapy.

2. Compare and contrast the roles of immunology and molecular oncology in cancer diagnosis and treatment.

3. What are the key genetic mechanisms that contribute to the development of cancer? Provide specific examples.

4. Explain the concept of precision medicine and provide examples of how molecular techniques are used to guide treatment.

5. Describe the molecular basis of a common hematological disorder and explain how this understanding informs current treatment approaches.

Sample Application Exercises

Exercise 1: You are a researcher studying a novel gene mutation associated with a neurodegenerative disorder. Outline the steps you would take to investigate the molecular function of the gene and its role in the disease.

Exercise 2: A patient has been diagnosed with a hematological malignancy. Describe the molecular diagnostic tools you would use to characterize the disease and guide treatment decisions.

Exercise 3: You are designing a gene therapy approach for a monogenic disorder. Outline the key considerations in vector selection, delivery, and therapeutic efficacy.

---

GLOSSARY OF KEY TERMS

---

RECOMMENDED RESOURCES

Primary Curriculum References

• Ziauddin University BS Molecular Medicine Curriculum – Comprehensive curriculum overview .

• Trinity College Dublin Molecular Medicine Modules – Module structure and topics .

• Imperial College London MSc Molecular Medicine – Advanced topics and research areas .

Supplementary Resources

• University of Western Australia Molecular Medicine Unit – Core concepts and learning outcomes .

• Universidade de Évora Molecular Medicine Course – Advanced topics in molecular medicine .

• Charles University Molecular Medicine Course – Genomics, gene therapy, and practical applications .

---

These notes cover the core content of the BS Molecular Medicine program. Mastery requires not just understanding the concepts but also developing practical research skills and the ability to apply molecular principles to real-world medical problems. The program emphasizes the integration of diverse branches of medical sciences, fostering the creation of innovative diagnostic and therapeutic techniques .

Modern Technologies in Molecular Biology: Bioinformatics, Genomics, Gene Editing, and Molecular Diagnostics

Study Notes

---

1. Bioinformatics: The Computational Backbone

Bioinformatics is the interdisciplinary field that develops methods and software tools for understanding biological data, particularly in genomics and molecular diagnostics .

1.1 Core Database Resources

Biological databases form the foundation of bioinformatics work:

Primary and Derivative Databases:

• GenBank: Primary nucleotide sequence repository

• UniProt: Protein sequence and functional information

• Gene Ontology (GO): Standardized vocabulary for gene functions across species

• Genome Browsers: UCSC Genome Browser, Ensembl for visualizing genomic data

• COSMIC: Catalogue of Somatic Mutations in Cancer 

Search and Analysis Tools:

• BLAST (Basic Local Alignment Search Tool): Compares query sequences against databases to identify homologous sequences 

• HMMER: Uses hidden Markov models for protein sequence analysis 

1.2 AI and Deep Learning in Bioinformatics

Recent Example – G2PDeep Platform (2025):
Researchers developed G2PDeep, a deep-learning framework that integrates six types of molecular data for phenotype prediction :

This platform demonstrates how AI can uncover biological mechanisms driving disease and treatment response across conditions including cancer, addiction, and aging .

Recent Example – ModVAR (2025):
A multimodal AI framework for predicting driver variants in cancer, integrating diverse data modalities to identify clinically relevant variants. It was benchmarked against 14 state-of-the-art methods and can model variants in intrinsically disordered protein regions .

1.3 Pharmacogenomic Bioinformatics

Bioinformatics tools are crucial for pharmacogenomic studies, analyzing gene polymorphisms linked to clinical outcomes. Challenges include managing cloud computing for healthcare data and developing parallel algorithms for large-scale genomic analysis .

---

2. Genomics: Decoding the Blueprint

Genomics encompasses the study of entire genomes, including sequencing, assembly, and functional annotation.

2.1 Sequencing Technologies

Next-Generation Sequencing (NGS) Platforms :

• Pyrosequencing: Detects pyrophosphate release during nucleotide incorporation

• Reversible Terminator Sequencing: Illumina platform using fluorescently labeled nucleotides

• SOLiD: Sequencing by oligonucleotide ligation and detection

• Ion Torrent: Detects hydrogen ions released during DNA polymerization

Third-Generation Sequencing:

• PacBio Sequencing: Long-read single-molecule sequencing enabling detection of structural variants and epigenetic modifications 

Recent Example – Nanopore RNA Methylation Profiling (2025):
Researchers successfully sequenced a 22-nucleotide RNA fragment (the shortest RNA species sequenced on Oxford Nanopore Technology platform) and characterized 2′-O-methylation (Nm) modifications at single-molecule resolution. This enables small RNA modification measurements in liquid biopsy tests for lung cancer detection .

2.2 Genomic Applications

Cancer Genomics:
Biliary tract cancer genomics has revealed actionable alterations in up to 40% of patients, including FGFR2 fusions, IDH1 mutations, HER2 amplification, and BRAF/KRAS mutations .

Liquid Biopsy:
Circulating free DNA (cfDNA) analysis has prognostic value in diffuse large B-cell lymphoma, with elevated cfDNA concentrations correlating with inferior overall survival .

Transcriptomics and Single-Cell Analysis:
NGS enables transcriptome analysis, metagenomics, microbiome studies, and single-cell analysis .

---

3. Gene Editing: Precision Genome Engineering

3.1 CRISPR-Cas9 System

Mechanism:

• Cas9 enzyme guided by single guide RNA (sgRNA) recognizes target DNA via complementary base pairing

• Requires a Protospacer Adjacent Motif (PAM) sequence for cleavage

• Creates double-strand breaks (DSBs) at the target site 

Web-Based CRISPR Design Tools:

• sgRNA Scorer 2.0: Species-independent model for predicting Cas9 activity

• CHOPCHOP, CRISPOR, and other platforms for guide RNA design 

Deep Learning for CRISPR Optimization:
AI models now predict both on-target efficiency and off-target effects, improving experimental design .

3.2 Beyond Cas9: Next-Generation CRISPR Systems

Recent Example – Engineered Cas12j-8 (2025):
A compact Cas nuclease (717 amino acids) from giant bacteriophages was engineered to achieve robust genome editing in mammalian cells. Key achievements :

• On-target editing efficiency comparable to LbCas12a

• Low off-target effects

• Multiplexed editing of three genomic loci simultaneously via a single crRNA array

• Base editing efficiencies up to 29.54-fold (C-to-T) and 36.57-fold (A-to-G)

• Potential for therapeutic exon skipping in SOD1 gene

Recent Example – EnDelIscB System (2025):
IscB, the putative ancestor of Cas9, offers compact size for in vivo delivery. Researchers developed enDelIscB with a 48.9-fold increase in activity and demonstrated :

• Robust editing in human cells and mouse embryos

• Miniature base editors (ICBE and IABE) via deaminase fusions

• Generation of mouse models through mRNA/sgRNA microinjection

Recent Example – PmMAD7 for Aquaculture (2025):
A Cas12a-family enzyme (MAD7) was optimized for gene editing in Penaeus monodon (black tiger shrimp), achieving knockout efficiencies of 14.81% and 20.57% for target genes, advancing sustainable aquaculture .

3.3 CRISPR in Diagnostics

CRISPR-based diagnostics use Cas enzymes (Cas12, Cas13) for rapid pathogen detection . These systems offer point-of-care capabilities with high sensitivity and specificity.

AI Integration:
The convergence of CRISPR with AI enables theranostic applications—combining therapeutic and diagnostic functions for personalized medicine .

3.4 Gene Editing in Neurosurgery

Precision Neuro-Oncology (2025):
Genomic profiling and CRISPR-Cas9 are integrated with multi-omics platforms for understanding CNS disorders. Biomarkers such as IDH mutations and MGMT promoter methylation have become critical for glioblastoma classification, guiding surgical approach and adjuvant therapy stratification .

---

4. Molecular Diagnostics: From Bench to Clinic

4.1 Nucleic Acid Amplification Techniques

PCR and RT-PCR:

• Standard PCR for detecting DNA mutations

• RT-PCR for RNA virus detection (e.g., SARS-CoV-2) and gene expression analysis 

• Real-time PCR for absolute quantification and genotyping 

Advanced PCR Technologies :

• Digital PCR and Droplet Digital PCR: Absolute quantification, valuable for cfDNA analysis and prenatal diagnosis

• High Resolution Melt (HRM) Analysis: SNP detection without sequencing

Recent Example – Enzyme-Mediated DNA Computing for Cancer Diagnosis (2025):
Researchers developed a polymerase-based DNA strand displacement system for molecular computing of multiple miRNAs. Using machine learning to identify seven diagnostic miRNAs for non-small cell lung cancer, the system achieved :

• 97.3% accuracy on 218 clinical samples

• 97.5% sensitivity and 94.7% specificity

• Weighted miRNA classification for diagnostic valence assignment

4.2 Microarray Technologies

• Planar and bead microarrays for transcriptome analysis

• SNP arrays for genotype characterization

• CGH arrays for copy number variation detection

• Microarrays for pathogen detection and characterization 

4.3 CRISPR-Based Rapid Diagnostics

Recent Example – Next-Generation CRISPR Diagnostics (2025):
Point-of-care CRISPR-based rapid diagnosis using Cas9, Cas12, and Cas13 enzymes has been advanced for pathogen detection (e.g., SARS-CoV-2) . These methods offer:

• Rapid, field-deployable detection

• High specificity via guide RNA targeting

• Compatibility with various readout platforms

4.4 Liquid Biopsy Applications

cfDNA analysis enables non-invasive cancer monitoring and prenatal diagnosis. Recent clinical studies demonstrate prognostic value of cfDNA concentrations in lymphoma and other malignancies .

---

5. Integration Across Technologies

5.1 Multi-Omics Platforms

Combining genomics, transcriptomics, proteomics, and metabolomics with AI enables comprehensive disease characterization . Platforms like G2PDeep demonstrate the power of integrating diverse data types for phenotype prediction .

5.2 Clinical Translation Challenges

• Balancing innovation with feasibility across diverse healthcare settings

• Ensuring access to genomic testing in resource-limited environments

• Managing ethical and technical challenges in genomic medicine implementation 

5.3 Emerging Frontiers

• Single-cell RNA sequencing: Enables unprecedented resolution of tissue heterogeneity

• Intraoperative mass spectrometry: Real-time molecular diagnostics during surgery

• AI-guided CRISPR: Precision genome editing with reduced off-target effects

• Miniature gene-editing tools: Enabling broader in vivo delivery options 

Clinical Laboratory Technologist: Molecular Testing and Genetic Screening

1. Role and Responsibilities

A Clinical Laboratory Technologist specializing in molecular diagnostics performs complex testing that detects genetic variations and infectious agents at the nucleic acid level. This role requires mastery of multiple methodologies, strict adherence to quality standards, and the analytical skill to interpret patient results accurately.

Core Responsibilities

Technical Testing: Perform high-complexity molecular assays including DNA/RNA extraction, polymerase chain reaction (PCR), real-time PCR, Sanger sequencing, and Next-Generation Sequencing (NGS). Testing applies to various specimen types—peripheral blood, prenatal samples (amniotic fluid, chorionic villi), saliva, and buccal swabs.

Documentation and Quality: Maintain complete, audit-ready documentation for all testing processes per standard operating procedures (SOPs). Participate in quality control reviews, identify deviations, investigate issues, and document corrective actions.

Troubleshooting and Validation: Troubleshoot assay, equipment, and reagent qualification issues. Participate in verification and validation studies for process improvements, new equipment, and technology transfers. Senior technologists contribute to research activities and departmental processes like test development.

Training and Leadership: Train new laboratory personnel on procedures and instrumentation. Senior technologists provide mentorship, support performance appraisals, and help organize workflow.

Qualifications

• Education: Bachelor’s degree in Chemical/Biological Science, Clinical Laboratory Science, or Medical Technology. Senior roles may prefer or require a Master’s degree.

• Experience: Minimum 1 year of clinical laboratory experience (or an MLS degree) required; prior molecular biology lab experience highly preferred. Senior technologist roles typically require 3-5 years recent molecular genetics experience.

• Certification: ASCP or AMT certification preferred in the US; in Canada, current registration with CMLTO in Molecular Genetics is required.

• Skills: Proficient with computers and Laboratory Information Systems (LIS); high attention to detail; strong communication and organizational skills; ability to pass a standardized color vision screen.

---

2. Molecular Testing Methods

Nucleic Acid Amplification Techniques (NAAT)

NAATs take minute amounts of DNA or RNA, replicate them many times, and thus detect traces of an organism or genetic variant, avoiding the need for culture. These techniques are especially valuable for organisms difficult to culture (viruses, intracellular pathogens, fungi, mycobacteria) or present in low numbers.

Polymerase Chain Reaction (PCR): The foundational amplification technique. A small amount of DNA can be amplified to produce millions of copies of a gene or genetic segment. RNA can be amplified by combining reverse transcriptase with traditional PCR (RT-PCR).

Real-Time PCR: Quantifies amplification as it occurs, allowing both detection and measurement of target sequences. Used for viral load monitoring (HIV, hepatitis B/C, CMV) to guide treatment decisions.

Multiplex Assays: Single tests that detect and differentiate ≥2 causative microorganisms, available for respiratory, gastrointestinal, and neurotropic pathogens. These are mostly qualitative and ordered in response to clinical syndromes.

Genetic Screening Technologies

Next-Generation Sequencing (NGS): Revolutionized genetic diagnostics by breaking the entire genome into small segments, sequencing them, and reassembling using computational techniques. This provides base-by-base sequence of the whole genome or limited regions like the exome. Costs have dramatically decreased, making NGS the cornerstone of modern genetic diagnosis. However, the vast information generated creates interpretative challenges.

DNA Microarrays (aCGH): Powerful tools identifying DNA mutations by comparing patient DNA to a reference genome using oligonucleotide probes. Array Comparative Genomic Hybridization (aCGH) routinely identifies deleted or duplicated DNA regions across entire chromosomes.

Probe-Based Methods: Gene probes locate specific segments of normal or mutated DNA. Fluorescence In Situ Hybridization (FISH) uses fluorescently labeled DNA probes that bind to complementary sequences, measurable by fluorescence quantity and type.

Sample Collection Criticals

Because amplification methods are highly sensitive, false-positive results from contamination can easily occur. False-negatives are minimized by: using validated swabs (not wooden shafts or cotton tips), transporting specimens rapidly, and refrigerating (not freezing) if labile viruses are suspected or cultures are needed.

---

3. Clinical Applications

Infectious Disease Detection

Molecular identification is now routine in clinical settings. Rapid identification allows specific antimicrobial therapy and avoids prolonged empiric, potentially inappropriate medications.

Key Applications:

• Respiratory pathogens (multiplex panels)

• Sexually transmitted infections (Chlamydia, gonorrhea)

• Viral load monitoring (HIV, hepatitis B/C, CMV)

• Meningoencephalitis pathogens

• Biological warfare agents

Emerging Technology – CRISPR Diagnostics: CRISPR-based systems (e.g., Cas12a DETECTR, Cas13a SHERLOCK) have entered clinical applications. Cas12a technology for HPV typing achieved 99.3% specificity and has received CE certification. A CRISPR/Cas12a-based method for detecting 14 high-risk HPV types demonstrated 100% clinical sensitivity and specificity in research settings.

For tuberculosis, CRISPR-SERS conjugation reduced detection limits to 4.42 pM (10-100× more efficient than qPCR) and achieved 100% accuracy in sputum samples, reducing multi-drug resistant TB identification from “weekly” to “hourly” levels.

For SARS-CoV-2, the RT-RAA-Cas13a system achieved portable detection of 1 copy/µL in 30 minutes.

Genetic Disease Screening

Molecular genetics laboratories test for inherited disorders such as cystic fibrosis, spinal muscular atrophy, and Fragile X syndrome using NGS, real-time PCR, Sanger sequencing, MLPA, and fragment analysis.

Constitutional Disorders: Ontario’s Molecular Genetics Laboratory supports provincial testing for epilepsy genetics and other constitutional disorders, serving oncologists, pathologists, pediatricians, geneticists, hematologists, and neurologists for diagnosis, prognosis, and treatment direction.

Oncology Applications: Assays include tumor cell enumeration, immunocytochemistry, FISH, and NGS to identify mutations driving cancer and guide targeted therapy.

---

4. Quality and Regulatory Framework

CLIA and Accreditation

Molecular technologists work in high-complexity CLIA-certified laboratories, requiring strict adherence to established protocols. Laboratories undergo inspections and audits by accrediting agencies; maintaining audit-ready records is essential.

Laboratory Information Systems

Proficiency with LIS and related computer systems is required for tracking specimens, documenting results, and ensuring traceability. Senior technologists may generate daily, weekly, and monthly reports.

Continuous Quality Improvement

Technologists contribute to ongoing process improvement, participate in quality assurance initiatives, and stay current with continuing education and competency assessment requirements.

---

Summary Table: Key Molecular Testing Methods

---

This material provides foundational knowledge of the Clinical Laboratory Technologist’s role in molecular diagnostics and genetic screening, emphasizing the technical methods, clinical applications, and quality imperatives that define this essential healthcare profession.

Forensic Scientist: Analyzing Biological Samples in Criminal Investigations

1. The Core Workflow: From Crime Scene to Courtroom

The analysis of biological evidence follows a structured, scientifically rigorous pathway. The primary goal is to first identify the biological material (e.g., is this stain blood or saliva?) and then individualize it (i.e., who did it come from?).

A. Evidence Recognition & Collection

• Sources: Blood, semen, saliva, vaginal secretions, urine, feces, and trace DNA from touched objects (“touch DNA”).

• Challenging Substrates: Items like knives, smartphones, and tapes are routinely analyzed, but recovery is highly variable. Environmental factors like submersion in water severely degrade DNA; submersion time is a critical factor, with freshwater yielding higher recovery than sewage water.

B. Forensic Serology (Body Fluid Identification)

This initial “screening” phase uses chemical, microscopic, and immunological tests to confirm the presence of a specific body fluid. Importantly, a positive serology test does not guarantee a full DNA profile—cells, the DNA-containing components, may be absent.

C. DNA Analysis & Profiling

If a body fluid is identified, the sample proceeds to DNA testing for individualization. This involves DNA extraction, quantification, amplification (PCR), and separation/analysis (capillary electrophoresis). The result is a DNA profile (a series of numbers for specific genetic markers) that can be compared to a reference sample. The technology used can be broken down into:

• The Gold Standard: Autosomal Short Tandem Repeats (STRs): STRs are short, repeating DNA sequences used for human identification. Modern STR kits analyze over 20 loci, providing probabilities of identity in the range of 10−2610−26 to 10−3110−31.

  • Mixture Interpretation: A major challenge is deconvoluting DNA from multiple contributors (mixtures). Detecting a minor contributor becomes difficult if their DNA is present at a ratio below 1:19 relative to the major contributor.

  • Degraded Samples: Heavily degraded DNA is a common problem. “Mini-STRs” (short amplicon STRs) are often used to recover profiles from such samples.

• When STRs Are Insufficient: For highly compromised samples or complex relationships, alternative markers are used.

  • Mitochondrial DNA (mtDNA): mtDNA is present in many more copies per cell than nuclear DNA and is more resilient to degradation. However, it is inherited only from the mother and cannot discriminate between individuals in the same maternal lineage. It is useful for degraded samples like hairs where the root is absent.

  • Y-STRs: These markers on the Y-chromosome are male-specific, useful in sexual assault cases with a high female DNA background. They trace the paternal lineage.

  • X-STRs: Markers on the X-chromosome, valuable for complex kinship cases, such as deficiency paternity cases.

---

2. Challenges and Emerging Technologies (2025-2026)

The field is rapidly evolving. Recent research and publications highlight both current limitations and promising new avenues.

A. Overcoming Degradation & Inhibition

• The “Forensic Window”: Research on buried samples shows that the window for obtaining usable DNA profiles is “significantly shorter and more complex than previously estimated,” primarily due to PCR inhibitors present in the environment (e.g., humic acid in soil).

• Mitigating Inhibitors: Techniques like “Hot Start” PCR and the use of additives (glycerol, DMSO) are employed to improve polymerase activity and binding in the presence of inhibitors.

B. Next Generation Sequencing (NGS)

NGS is a paradigm shift, allowing for massively parallel sequencing of DNA. This technology can simultaneously analyze hundreds of genetic markers, providing more information than the current CE-based STR analysis. This offers advantages in:

• Analyzing complex mixtures and highly degraded samples.

• Simultaneously analyzing STRs, SNPs, and mtDNA.

• Generating investigative leads (see below).

C. Investigative & Predictive DNA Analysis

This is a rapidly growing field that moves beyond human identification to generate leads for investigations.

• Forensic DNA Phenotyping (FDP): Using DNA to predict physical appearance (e.g., eye color, hair color, ancestry). This relies on single nucleotide polymorphisms (SNPs), as STRs are typically in non-coding DNA and are not informative for physical traits.

• Investigative Genetic Genealogy (IGG): Uploading a forensic DNA profile to public genetic genealogy databases to find relatives of an unknown suspect, effectively building a family tree to generate a lead. This is noted as a major modern advancement.

D. Body Fluid Identification: New Approaches

• Metabolomics: Metabolites, the small molecules produced by cellular processes, show promise for body fluid identification. A 2025 pilot study used an untargeted metabolomics approach with UPLC-QTOF-MS to distinguish between nine different body fluids and tissues (including blood, semen, saliva, urine, and feces), potentially overcoming limitations of protein-based assays.

• mRNA Markers: The analysis of messenger RNA (mRNA) is another emerging technique for identifying body fluids, offering high specificity.

---

Summary Table: Key Analytical Techniques